Skip to main content
HR 6577 115th Congress House Health Intellectual property Prescription drugs

PRICED Act

Introduced: July 26, 2018 Introduced by: Schakowsky, Janice D. Democratic · Illinois See on congress.gov
Sign in to write a letter Sign in to watch
 Everywhere this bill has been 3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jul 27, 2018
Referred to the Subcommittee on Health.
Jul 26, 2018
Referred to the House Committee on Energy and Commerce.
Jul 26, 2018
Introduced in House
 Plain-English summary Congressional Research Service

Price Relief, Innovation, and Competition for Essential Drugs Act or the PRICED Act

This bill amends the Public Health Service Act to allow biosimilars to be marketed seven years after the reference brand name biological product is licensed. Currently, brand name biological products are provided a 12-year marketing exclusivity period.

This shortened marketing exclusivity period applies only to biological products licensed by the Food and Drug Administration after enactment of this bill.

What's happening now July 27, 2018

Referred to the Subcommittee on Health.

 Committees of jurisdiction 2